January 2024 Tender notification
Download the Tender Notification [PDF 164 KB]
Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2021/22 Invitation to Tender, dated 1 November 2021.
Some of the Pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with Pharmac. Suppliers of Pharmaceuticals that are subject to such contracts should continue to supply their Pharmaceuticals under those contracts. Pharmac will continue to subsidise those Pharmaceuticals accordingly until such time as those Pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:
- For new listings, by 4pm on the 12th of February 2024 or the 5th of the month prior to listing, whichever is earlier
- For price changes, by 4pm on the 12th of the month prior to the date of subsidy change
Pharmac cannot list a product (and Pharmacies cannot claim) without this information. More information about this process, and a copy of the NOPC form can be found on our website.
Process for notification of product changes
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to Pharmac by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). Pharmac cannot list a product (and Pharmacies cannot claim) without the correct Pharmacode
2021/22 Tender – Principal Supply Status applies until 30 June 2025
Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule
The decisions were as follows:
1. Tenders awarded to pharmaceuticals where at least one other brand is listed.
| Chemical name | Presentation; Pack size and type |
Current pack price | New pack price | Principal Supply brand (Supplier) |
Listing date | Principal Supply date |
Brand affected by delisting (Supplier) |
|---|---|---|---|---|---|---|---|
| Phenobarbitone1
|
Tab 15 mg; 500 tablet bottle
|
$40.00
|
$248.50
|
Noumed Phenobarbitone (Noumed)
|
1 March 2024
|
1 August 2024
|
PSM (API Consumer Brands)
|
| 1Brand switch fee of $4.50 is payable for this product from 1 August 2024 to 31 October 2024 | |||||||
Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.
2. Tenders awarded to pharmaceuticals where at least one other brand is listed.
| Chemical name | Presentation; Pack size and type |
Current pack price | New pack price | Principal Supply brand (Supplier) |
DV limit | Listing date | Principal Supply date | Supplier affected by delisting (Brand) |
|---|---|---|---|---|---|---|---|---|
| Phenobarbitone
|
Tab 15 mg; 500 tablet bottle
|
$40.00
|
$248.50
|
Noumed Phenobarbitone (Noumed)
|
5%
|
1 March 2024
|
1 August 2024
|
PSM (API Consumer Brands)
|
For products included in the 2021/22, 2022/2023 and 2023/24 Invitation to Tender where no announcement has yet been made, either a decision is still pending subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.